Taken together, we concluded that lncSLCO1C1 mediate tumour resistance to chemotherapy with oxaliplatin by enhancing SSRP1‐induced DNA repair in GC cells, resulting in poor patient overall survival. Here, SSRP1 is linked to neoplasm.